Publications dans lesquelles il/elle collabore avec Maria Inmaculada Heras Fernando (15)

2021

  1. Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers

    Transplantation and Cellular Therapy, Vol. 27, Núm. 6, pp. 493.e1-493.e8

2019

  1. Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma

    Biology of Blood and Marrow Transplantation, Vol. 25, Núm. 9, pp. 1703-1712

2017

  1. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

2015

  1. Outcome of graft failure after allogeneic stem cell transplant: Study of 89 patients

    Leukemia and Lymphoma, Vol. 56, Núm. 3, pp. 656-662

2006

  1. L-asparaginase-induced antithrombin type I deficiency: Implications for conformational diseases

    American Journal of Pathology, Vol. 169, Núm. 1, pp. 142-153

1999

  1. Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer

    Bone Marrow Transplantation, Vol. 23, Núm. 6, pp. 621-624

  2. Preleukapheresis peripheral blood CD34+ cells predict progenitor cell collection yield and the necessary number of procedures to undergo [2]

    Haematologica

1998

  1. Bone marrow steady-state CD34+/CD71- cell content is a predictive value of rG-CSF-mobilized CD34+ cells

    Bone Marrow Transplantation, Vol. 21, Núm. 10, pp. 983-985

1997

  1. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors

    Bone Marrow Transplantation, Vol. 20, Núm. 6, pp. 451-458

  2. Differences in phycoerythrin- or fluorescein-isothiocyanate conjugated 8G12 on CD34+ cell evaluation

    Haematologica, Vol. 82, Núm. 3, pp. 334-335

  3. Disseminated aspergillosis after mobilization with intensive chemotherapy prior to autologous stem-cell transplant in chronic myeloid leukemia [1]

    American Journal of Hematology

  4. Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG-CSF for mobilizing peripheral blood progenitor cells

    British Journal of Haematology, Vol. 96, Núm. 2, pp. 418-420

1996

  1. Coste económico del autotrasplante de progenitores hematopoyéticos

    Medicina Clinica, Vol. 106, Núm. 9, pp. 329-332

  2. Immune recovery after autologous or rhG-CSF primed PBSC transplantation

    European Journal of Haematology, Vol. 56, Núm. 5, pp. 301-307

1995

  1. The follow-up of the mobilization of circulating hematopoietic progenitor cells by granulocyte growth factor (G-CSF) using flow cytometry

    Medicina clínica, Vol. 104, Núm. 2, pp. 41-44